Feasibility of a Pharmabuddy Care Service for patients with Parkinson’s disease
This study shows PCS is highly appreciated by responding patients and can be feasible for primary care pharmacies. Several implementation issues are still present. Future studies should focus on quantifiable effects of PCS services as well as resource and perception hurdles.
Authors
- Teus van Laar (ORCID: https://orcid.org/0000-0001-5088-480X)
- Mette Heringa (ORCID: https://orcid.org/0000-0001-8316-8148)
- Bart J. F. van den Bemt (ORCID: https://orcid.org/0000-0002-8560-9514)
- Fatma Karapinar‐Çarkit (ORCID: https://orcid.org/0000-0002-3077-9663)
- Clementine C. M. Stuijt (ORCID: https://orcid.org/0000-0002-5514-7195)
- C Gompel
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- University of Groningen (NL)
- Maastricht University Medical Centre (NL)
- Radboud University Medical Center (NL)
- Maastricht University (NL)
- Parkinson's UK (GB)
- Sint Maartenskliniek (NL)
- SIR Institute for Pharmacy Practice and Policy (NL)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12913-024-12057-x
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00